Last updated: July 11, 2023
Sponsor: University of Toronto
Overall Status: Active - Recruiting
Phase
N/A
Condition
Aging
Muscular Dystrophy
Sarcopenia
Treatment
Metabolic Trial
15 sit-to-stands with calf raises
Clinical Study ID
NCT05810272
ESPEN
Ages 60-80 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Healthy older (age: 60-80 y) adults
- BMI between normal to overweight (18.5-29.9 kg/m2)
Exclusion
Exclusion Criteria:
- Regular use of nonsteroidal anti-inflammatory drugs (with the exception of dailylow-dose aspirin)
- Alcohol consumption during the study period
- Use of anticoagulants
- Use of a walker, cane, or assistive walking device
- Current or recently remised cancer
- Infectious or gastrointestinal disease
- Inability to comply with study protocol (e.g., >1,500 steps/day during Step-ReductionPhase)
- Regular tobacco use
- Self-reported illicit drug use (e.g. growth hormone, testosterone, etc.)
- Diagnosed chronic illness (e.g. type 2 diabetes, heart disease, thyroid disease)
- Hormonal Replacement Therapy
Study Design
Total Participants: 20
Treatment Group(s): 2
Primary Treatment: Metabolic Trial
Phase:
Study Start date:
April 01, 2023
Estimated Completion Date:
August 01, 2024
Study Description
Connect with a study center
Goldring Center for High Performance Sport
Toronto, Ontario M5S 2C9
CanadaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.